Tuberculosis/therapy[Mesh] - Search Results

Year	Number of Results
1946	5
1947	8
1948	20
1949	12
1950	17
1951	29
1952	54
1953	47
1954	32
1955	37
1956	20
1957	18
1958	19
1959	20
1960	13
1961	12
1962	9
1965	7
1966	25
1967	27
1968	25
1969	34
1970	29
1971	52
1972	33
1973	33
1974	26
1975	22
1976	31
1977	19
1978	23
1979	29
1980	30
1981	15
1982	26
1983	41
1984	30
1985	25
1986	24
1987	20
1988	34
1989	30
1990	38
1991	27
1992	63
1993	73
1994	78
1995	96
1996	109
1997	102
1998	127
1999	147
2000	160
2001	172
2002	202
2003	216
2004	232
2005	273
2006	361
2007	437
2008	436
2009	526
2010	616
2011	708
2012	881
2013	996
2014	1030
2015	1150
2016	1094
2017	1163
2018	1095
2019	1148
2020	1346
2021	1350
2022	1228
2023	1011
2024	316

1

Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho.

Oyewusi L, Zeng C, Seung KJ, Mpinda S, Kunda M, Mitnick CD, Kanu M, Tamirat M, Makaka J, Mofolo M, Maime R, Maama L, Senyo N, Oguntoyinbo B, Mayombo L, Franke MF. Oyewusi L, et al. Glob Health Action. 2024 Dec 31;17(1):2305930. doi: 10.1080/16549716.2024.2305930. Epub 2024 Feb 2. Glob Health Action. 2024. PMID: 38305025 Free PMC article.

2

Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?

Antas PRZ, Flores-Valdez MA, Locht C. Antas PRZ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2300158. doi: 10.1080/21645515.2023.2300158. Epub 2024 Jan 29. Hum Vaccin Immunother. 2024. PMID: 38287731 Free PMC article. No abstract available.

3

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice.

Fang D, Wang R, Fan X, Li M, Qian C, Cao B, Yu J, Liu H, Lou Y, Wan K. Fang D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2299607. doi: 10.1080/21645515.2023.2299607. Epub 2024 Jan 23. Hum Vaccin Immunother. 2024. PMID: 38258510 Free PMC article.

4

Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in mice.

Ahmed M, Farris E, Swanson RV, Das S, Yang Y, Martin T, Khader SA. Ahmed M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2302070. doi: 10.1080/21645515.2024.2302070. Epub 2024 Jan 8. Hum Vaccin Immunother. 2024. PMID: 38190806 Free PMC article.

5

Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis.

Khattak M, Rehman AU, Muqaddas T, Hussain R, Rasool MF, Saleem Z, Almalki MS, Alturkistani SA, Firash SZ, Alzahrani OM, Bahauddin AA, Abuhussain SA, Najjar MF, Elsabaa HMA, Haseeb A. Khattak M, et al. Ann Med. 2024 Dec;56(1):2313683. doi: 10.1080/07853890.2024.2313683. Epub 2024 Feb 12. Ann Med. 2024. PMID: 38346381 Free PMC article.

6

Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study.

Li M, Zhang Y, Wu Z, Jiang Y, Sun R, Yang J, Li J, Lin H, Zhang R, Jiang Q, Wang L, Wu X, Yu F, Yuan J, Yang C, Shen X. Li M, et al. Emerg Microbes Infect. 2024 Dec;13(1):2302837. doi: 10.1080/22221751.2024.2302837. Epub 2024 Jan 22. Emerg Microbes Infect. 2024. PMID: 38205528 Free PMC article.

7

Incidence, risk factors for active tuberculosis infection and changes of IGRA in patients with Takayasu arteritis: a prospective cohort study.

Peng Z, Li J, Rong Z, Zhou Y, Wang Y, Wang Y, Zhang G, Yang Y, Tian X, Zeng X. Peng Z, et al. Emerg Microbes Infect. 2024 Dec;13(1):2302099. doi: 10.1080/22221751.2024.2302099. Epub 2024 Jan 22. Emerg Microbes Infect. 2024. PMID: 38166581 Free PMC article.

8

A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis.

Hu Z, Xia J, Wu J, Zhao H, Ji P, Gu L, Gu W, Chen Z, Xu J, Huang X, Ma J, Chen A, Li J, Shu T, Fan XY. Hu Z, et al. Emerg Microbes Infect. 2024 Dec;13(1):2300463. doi: 10.1080/22221751.2023.2300463. Epub 2024 Jan 4. Emerg Microbes Infect. 2024. PMID: 38164736 Free PMC article.

9

Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations.

Jaramillo-Valverde L, Levano KS, Tarazona DD, Capristano S, Sanchez C, Poterico JA, Tarazona-Santos E, Guio H. Jaramillo-Valverde L, et al. Pharmacol Res Perspect. 2024 Jun;12(3):e1179. doi: 10.1002/prp2.1179. Pharmacol Res Perspect. 2024. PMID: 38666760 Free PMC article.

10

Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case-control study.

Zereabruk K, Kahsay T, Teklemichael H, Aberhe W, Hailay A, Mebrahtom G, Bezabh G. Zereabruk K, et al. BMJ Open Respir Res. 2024 May 2;11(1):e001999. doi: 10.1136/bmjresp-2023-001999. BMJ Open Respir Res. 2024. PMID: 38697676 Free article.

11

Comparative evaluation of intensified short course regimen and standard regimen for adults TB meningitis: a protocol for an open label, multi-center, parallel arms, randomized controlled superiority trial (INSHORT trial).

Inbaraj LR, Manesh A, Ponnuraja C, Bhaskar A, Srinivasalu VA, Daniel BD. Inbaraj LR, et al. Trials. 2024 May 2;25(1):294. doi: 10.1186/s13063-024-08133-6. Trials. 2024. PMID: 38693583 Free article.

12

Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis.

Kengo A, Nabeemeeah F, Denti P, Sabet R, Okyere-Manu G, Abraham P, Weisner L, Mosala MH, Tshabalala S, Scholefield J, Resendiz-Galvan JE, Martinson NA, Variava E. Kengo A, et al. Antimicrob Agents Chemother. 2024 May 2;68(5):e0158323. doi: 10.1128/aac.01583-23. Epub 2024 Apr 10. Antimicrob Agents Chemother. 2024. PMID: 38597667 Free article.

13

Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.

Bhanushali A, Atre S, Nair P, Thandaseery GA, Shah S, Kuruwa S, Zade A, Nikam C, Gomare M, Chatterjee A. Bhanushali A, et al. Microbiol Spectr. 2024 May 2;12(5):e0277023. doi: 10.1128/spectrum.02770-23. Epub 2024 Apr 10. Microbiol Spectr. 2024. PMID: 38597637 Free article.

14

Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis.

Lyons MA, Obregon-Henao A, Ramey ME, Bauman AA, Pauly S, Rossmassler K, Reid J, Karger B, Walter ND, Robertson GT. Lyons MA, et al. Antimicrob Agents Chemother. 2024 May 2;68(5):e0101023. doi: 10.1128/aac.01010-23. Epub 2024 Mar 19. Antimicrob Agents Chemother. 2024. PMID: 38501805 Free article.

15

Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.

Reeve BWP, Ndlangalavu G, Mishra H, Palmer Z, Tshivhula H, Rockman L, Naidoo S, Mbu DL, Naidoo CC, Derendinger B, Walzl G, Malherbe ST, van Helden PD, Semitala FC, Yoon C, Gupta RK, Noursadeghi M, Warren RM, Theron G. Reeve BWP, et al. Lancet Glob Health. 2024 May;12(5):e793-e803. doi: 10.1016/S2214-109X(24)00052-4. Epub 2024 Apr 4. Lancet Glob Health. 2024. PMID: 38583458 Free PMC article.

16

Tuberculosis treatment-shortening.

Singh V. Singh V. Drug Discov Today. 2024 May;29(5):103955. doi: 10.1016/j.drudis.2024.103955. Epub 2024 Mar 26. Drug Discov Today. 2024. PMID: 38548262 Free article. Review.

17

A Global Tuberculosis Dictionary: unified terms and definitions for the field of tuberculosis.

Garcia-Basteiro AL, Ehrlich J, Bonnet M, Calnan M, Graham SM, Hermans S, Jarrett A, Lewa R, Mandalakas A, Martinez L, Migliori GB, Ong CWM, Otero L, Rangaka MX, Raviglione MCB, Seaworth B, Ssengooba W, Theron G, Trajman A, Behr MA. Garcia-Basteiro AL, et al. Lancet Glob Health. 2024 May;12(5):e737-e739. doi: 10.1016/S2214-109X(24)00083-4. Epub 2024 Mar 22. Lancet Glob Health. 2024. PMID: 38527468 Free article. No abstract available.

18

Lysosomal enzymes and the oxygen burst capability of monocyte-derived macrophages in active drug-resistant tuberculosis patients in relation to cell attachment.

Iswanti FC, Handayani KM, Kusumaningrum A, Yamazaki T, Handayani D, Sadikin M. Iswanti FC, et al. Tuberculosis (Edinb). 2024 May;146:102498. doi: 10.1016/j.tube.2024.102498. Epub 2024 Feb 24. Tuberculosis (Edinb). 2024. PMID: 38461765 Free article.

19

Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus.

Yang JJ, Goff A, Wild DJ, Ding Y, Annis A, Kerber R, Foote B, Passi A, Duerksen JL, London S, Puhl AC, Lane TR, Braunstein M, Waddell SJ, Ekins S. Yang JJ, et al. Tuberculosis (Edinb). 2024 May;146:102500. doi: 10.1016/j.tube.2024.102500. Epub 2024 Feb 27. Tuberculosis (Edinb). 2024. PMID: 38432118 Free article.

20

Transmission of drug-resistant Mycobacterium tuberculosis isolates between Finnish- and foreign-born cases, 2014-2021: A molecular epidemiological study.

Zhu J, Haanpera M, Mentula S, Vapalahti O, Soini H, Sironen T, Kant R, Zakham F. Zhu J, et al. Tuberculosis (Edinb). 2024 May;146:102492. doi: 10.1016/j.tube.2024.102492. Epub 2024 Feb 12. Tuberculosis (Edinb). 2024. PMID: 38364331 Free article.

21

Implementing a continuous quality-improvement framework for tuberculosis infection prevention and control in healthcare facilities in China, 2017-2019.

Zhang C, O'Connor S, Smith-Jeffcoat SE, Rodriguez DF, Guo H, Hao L, Chen H, Sun Y, Li Y, Xu J, Chen L, Xia L, Yang X, Date A, Cheng J. Zhang C, et al. Infect Control Hosp Epidemiol. 2024 May;45(5):651-657. doi: 10.1017/ice.2023.287. Epub 2024 Jan 25. Infect Control Hosp Epidemiol. 2024. PMID: 38268435 Free PMC article.

22

Association between TB delay and TB treatment outcomes in HIV-TB co-infected patients: a study based on the multilevel propensity score method.

Liao R, Hu L, Yu J, Chen Y, Chen M, Yan J, Li X, Han X, Jike C, Yu G, Wang J, Liao Q, Xia L, Bai X, Shi J, Jiang T, Du L, Zhang T. Liao R, et al. BMC Infect Dis. 2024 Apr 30;24(1):457. doi: 10.1186/s12879-024-09328-7. BMC Infect Dis. 2024. PMID: 38689228 Free article.

23

Exploring health care providers' engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study.

Lajore BA, Aweke YH, Ayanto SY, Ayele M. Lajore BA, et al. BMC Health Serv Res. 2024 Apr 27;24(1):542. doi: 10.1186/s12913-024-10911-6. BMC Health Serv Res. 2024. PMID: 38678263 Free PMC article.

24

A new neonatal BCG vaccination pathway in England: a mixed methods evaluation of its implementation.

Jones K, Chisnall G, Crocker-Buque T, Elliman D, Horwood J, Mounier-Jack S, Campbell CN, Saliba V, Chantler T. Jones K, et al. BMC Public Health. 2024 Apr 26;24(1):1175. doi: 10.1186/s12889-024-18586-8. BMC Public Health. 2024. PMID: 38671383 Free PMC article.

25

Allograft tuberculosis in a kidney transplant recipient.

Siek K, Fedak A, Sączek A, Gołasa-Szczepaniak P, Krzanowski M, Krzanowska K. Siek K, et al. Pol Arch Intern Med. 2024 Apr 26;134(4):16701. doi: 10.20452/pamw.16701. Epub 2024 Mar 15. Pol Arch Intern Med. 2024. PMID: 38501599 Free article. No abstract available.

26

A proposal to evaluate the management of tuberculosis programs: a qualitative, evaluability assessment in the border region of Brazil and Venezuela.

Soares DA, Arcêncio RA, Fronteira I. Soares DA, et al. Cad Saude Publica. 2024 Apr 22;40(3):e00104823. doi: 10.1590/0102-311XEN104823. eCollection 2024. Cad Saude Publica. 2024. PMID: 38656066 Free PMC article.

27

Tuberculosis treatment during the COVID-19 pandemic: actions offered and case profile.

Antunes LB, Andrade RLP, Ribeiro RR, Monroe AA, Signor E, Bianchini ASMO, Veira NF, Gonzales RIC. Antunes LB, et al. Rev Gaucha Enferm. 2024 Apr 22;45:e20230127. doi: 10.1590/1983-1447.2024.20230127.en. eCollection 2024. Rev Gaucha Enferm. 2024. PMID: 38655930 Free article. English, Portuguese.

28

Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis.

Villa S, de Colombani P, Dall'Olio L, Gargioni G, Raviglione M. Villa S, et al. BMJ Glob Health. 2024 Apr 22;9(4):e014630. doi: 10.1136/bmjgh-2023-014630. BMJ Glob Health. 2024. PMID: 38649181 Free PMC article.

29

Recombinant mycobacterial DNA-binding protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vaccinated individuals' blood cells in combination with CpG-DNA.

Ozeki Y, Yokoyama A, Nishiyama A, Yoshida Y, Ohara Y, Mashima T, Tomiyama C, Shaban AK, Takeishi A, Osada-Oka M, Yamaguchi T, Tateishi Y, Maeyama JI, Hakamata M, Moro H, Kikuchi T, Hayashi D, Suzuki F, Yamamoto T, Iho S, Katahira M, Yamamoto S, Matsumoto S. Ozeki Y, et al. Sci Rep. 2024 Apr 21;14(1):9141. doi: 10.1038/s41598-024-58836-8. Sci Rep. 2024. PMID: 38644371 Free PMC article.

30

GenoMycAnalyzer: a web-based tool for species and drug resistance prediction for Mycobacterium genomes.

Kim D, Shin JI, Yoo IY, Jo S, Chu J, Cho WY, Shin SH, Chung YJ, Park YJ, Jung SH. Kim D, et al. BMC Genomics. 2024 Apr 20;25(1):387. doi: 10.1186/s12864-024-10320-3. BMC Genomics. 2024. PMID: 38643090 Free PMC article.

31

Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients.

Le X, Qian X, Liu L, Sun J, Song W, Qi T, Wang Z, Tang Y, Xu S, Yang J, Wang J, Chen J, Zhang R, Zhu Z, Shen Y. Le X, et al. Viruses. 2024 Apr 18;16(4):627. doi: 10.3390/v16040627. Viruses. 2024. PMID: 38675968 Free PMC article.

32

Tuberculosis patients face high treatment support costs in Colombia, 2021.

Cruz Martínez OA, García I, Puerto GM, Alvis-Zakzuk NJ, López MP, Moreno Cubides JC, Sánchez Salazar ÁM, Trujillo Trujillo J, Castro-Osorio CM, Vanessa Rubio V, Castañeda-Orjuela C, Montoro E, Nguhiu P, García Baena I. Cruz Martínez OA, et al. PLoS One. 2024 Apr 18;19(4):e0296250. doi: 10.1371/journal.pone.0296250. eCollection 2024. PLoS One. 2024. PMID: 38635755 Free PMC article.

33

A systematic review of economic evaluations of pharmacological treatments for active tuberculosis.

Nagar S, Nicholls D, Dawoud D. Nagar S, et al. Front Public Health. 2024 Apr 16;12:1201512. doi: 10.3389/fpubh.2024.1201512. eCollection 2024. Front Public Health. 2024. PMID: 38689771 Free PMC article.

34

Mental health issues associated with the management of tuberculosis in Homabay, Busia and Kakamega Counties, Kenya.

Otieno J, Luciani A, Lumumba S, Gikunda G, Kiilu C, Ogutu N, Sifuma B, Kinyua D, Mukami D, Mwenda C, Ronoh A, Opanga Y. Otieno J, et al. PLoS One. 2024 Apr 16;19(4):e0298268. doi: 10.1371/journal.pone.0298268. eCollection 2024. PLoS One. 2024. PMID: 38626202 Free PMC article.

35

Guidelines for tuberculosis screening and preventive treatment among pregnant and breastfeeding women living with HIV in PEPFAR-supported countries.

Hirsch-Moverman Y, Hsu A, Abrams EJ, Killam WP, Moore B, Howard AA. Hirsch-Moverman Y, et al. PLoS One. 2024 Apr 16;19(4):e0296993. doi: 10.1371/journal.pone.0296993. eCollection 2024. PLoS One. 2024. PMID: 38625930 Free PMC article. Review.

36

Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017.

Gonzalez-Reyes R, Katz D, Lambert L, Sorri Y, Narita M, Horne DJ; Tuberculosis Epidemiologic Studies Consortium. Gonzalez-Reyes R, et al. PLoS One. 2024 Apr 16;19(4):e0298628. doi: 10.1371/journal.pone.0298628. eCollection 2024. PLoS One. 2024. PMID: 38625902 Free PMC article.

37

[Current status of surgical treatment for angular kyphosis in spinal tuberculosis].

Zheng S, Song Y, Wang L. Zheng S, et al. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Apr 15;38(4):487-492. doi: 10.7507/1002-1892.202311059. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024. PMID: 38632071 Free PMC article. Chinese.

38

Tuberculosis Therapy in Children: Past, Present and Future Perspectives.

Mathew JL. Mathew JL. Indian Pediatr. 2024 Apr 15;61(4):383-386. Indian Pediatr. 2024. PMID: 38597105 Free article. No abstract available.

39

Integration of HIV Testing in a Community Intervention for Tuberculosis Screening Among Household Contacts of Patients with Tuberculosis in Cameroon and Uganda.

Youngui BT, Atwine D, Otai D, Vasiliu A, Ssekyanzi B, Sih C, Kana R, Arinaitwe R, Cuer B, Simo L, Okello R, Tchendjou P, Casenghi M, Kuate AK, Turyahabwe S, Cohn J, Bonnet M, Tchounga BK; CONTACT Study Group. Youngui BT, et al. J Acquir Immune Defic Syndr. 2024 Apr 15;95(5):431-438. doi: 10.1097/QAI.0000000000003379. Epub 2024 Mar 11. J Acquir Immune Defic Syndr. 2024. PMID: 38489492 Free PMC article.

40

Bactericidal Permeability-Increasing Protein (BPI) Inhibits Mycobacterium tuberculosis Growth.

Guzmán-Beltrán S, Juárez E, Cruz-Muñoz BL, Páez-Cisneros CA, Sarabia C, González Y. Guzmán-Beltrán S, et al. Biomolecules. 2024 Apr 13;14(4):475. doi: 10.3390/biom14040475. Biomolecules. 2024. PMID: 38672491 Free PMC article.

41

Predictors of quality of life of TB/HIV co-infected patients in the Northern region of Ghana.

Nabei JN, Bonful HA, Afari EA, Mohammed AG, Anum A. Nabei JN, et al. BMC Infect Dis. 2024 Apr 12;24(1):396. doi: 10.1186/s12879-024-09247-7. BMC Infect Dis. 2024. PMID: 38609839 Free PMC article.

42

Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis.

Song YK, Lee J, Jo J, Kwon JW. Song YK, et al. RMD Open. 2024 Apr 12;10(2):e003946. doi: 10.1136/rmdopen-2023-003946. RMD Open. 2024. PMID: 38609319 Free PMC article.

43

Trends and risk factors for drug-resistant tuberculosis among children in Sichuan, China: A 10-year retrospective analysis, 2013-2022.

Li M, Deng B, Huang Y, Li Q, Han J, Tang S, Chen L. Li M, et al. Medicine (Baltimore). 2024 Apr 12;103(15):e37643. doi: 10.1097/MD.0000000000037643. Medicine (Baltimore). 2024. PMID: 38608104 Free PMC article.

44

Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials?

Cross GB, O' Doherty J, Chang CC, Kelleher AD, Paton NI. Cross GB, et al. J Infect Dis. 2024 Apr 12;229(4):1229-1238. doi: 10.1093/infdis/jiad425. J Infect Dis. 2024. PMID: 37788578 Free PMC article. Review.

45

Linezolid Population Pharmacokinetic Model in Plasma and Cerebrospinal Fluid Among Patients With Tuberculosis Meningitis.

Abdelgawad N, Wasserman S, Abdelwahab MT, Davis A, Stek C, Wiesner L, Black J, Meintjes G, Wilkinson RJ, Denti P. Abdelgawad N, et al. J Infect Dis. 2024 Apr 12;229(4):1200-1208. doi: 10.1093/infdis/jiad413. J Infect Dis. 2024. PMID: 37740554 Free PMC article. Clinical Trial.

46

HtpG-A Major Virulence Factor and a Promising Vaccine Antigen against Mycobacterium tuberculosis.

Berisio R, Barra G, Napolitano V, Privitera M, Romano M, Squeglia F, Ruggiero A. Berisio R, et al. Biomolecules. 2024 Apr 11;14(4):471. doi: 10.3390/biom14040471. Biomolecules. 2024. PMID: 38672487 Free PMC article. Review.

47

Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.

Darge T, Babusha A, Chilo D, Dukessa A, Teferi S. Darge T, et al. Sci Rep. 2024 Apr 11;14(1):8473. doi: 10.1038/s41598-024-57900-7. Sci Rep. 2024. PMID: 38605149 Free PMC article.

48

Strategies to resolve the gap in adolescent tuberculosis care at four health facilities in Uganda: The teenager's TB pilot project.

Omongot S, Muttamba W, Najjingo I, Baruch Baluku J, Kitaka S, Turyahabwe S, Kirenga B. Omongot S, et al. PLoS One. 2024 Apr 11;19(4):e0286894. doi: 10.1371/journal.pone.0286894. eCollection 2024. PLoS One. 2024. PMID: 38603636 Free PMC article.

49

Dancing Out of Step: A Case of Tuberculous Meningitis Presenting as Childhood Chorea.

Garcia JJB, Tecson-Delos Santos CMA. Garcia JJB, et al. Tremor Other Hyperkinet Mov (N Y). 2024 Apr 10;14:17. doi: 10.5334/tohm.871. eCollection 2024. Tremor Other Hyperkinet Mov (N Y). 2024. PMID: 38617830 Free PMC article. Review.

50

Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.

Fuller NM, McQuaid CF, Harker MJ, Weerasuriya CK, McHugh TD, Knight GM. Fuller NM, et al. PLoS Pathog. 2024 Apr 10;20(4):e1011574. doi: 10.1371/journal.ppat.1011574. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38598556 Free PMC article.

51

Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitis.

Tram TTB, Trieu LPT, Nhat LTH, Thu DDA, Quang NL, Bang ND, Chau TTH, Thwaites GE, Walker TM, Ha VTN, Thuong NTT. Tram TTB, et al. J Clin Microbiol. 2024 Apr 10;62(4):e0128723. doi: 10.1128/jcm.01287-23. Epub 2024 Mar 11. J Clin Microbiol. 2024. PMID: 38466092 Free PMC article.

52

Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis.

Fan C, Eedara BB, Sinha S, Uddin MKM, Doyle C, Banu S, Das SC. Fan C, et al. Int J Pharm. 2024 Apr 10;654:123984. doi: 10.1016/j.ijpharm.2024.123984. Epub 2024 Mar 9. Int J Pharm. 2024. PMID: 38461874 Free article.

53

Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis.

Shao Z, Tam KK, Achalla VPK, Woon ECY, Mason AJ, Chow SF, Yam WC, Lam JKW. Shao Z, et al. Int J Pharm. 2024 Apr 10;654:123960. doi: 10.1016/j.ijpharm.2024.123960. Epub 2024 Mar 4. Int J Pharm. 2024. PMID: 38447778 Free article.

54

Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.

Mariner-Llicer C, Saavedra Cervera B, Mambuque E, Gomes N, Munguambe S, Villamayor L, Cancino-Muñoz I, Torres-Puente M, Nguenha D, Respeito D, Tembe G, López MG, Comas I, García-Basteiro AL. Mariner-Llicer C, et al. Clin Infect Dis. 2024 Apr 10;78(4):842-845. doi: 10.1093/cid/ciad684. Clin Infect Dis. 2024. PMID: 38048599 Free PMC article.

55

The predictors of voluntary participation in pulmonary tuberculosis screening program: a study in a suburban community of southern Thailand.

Kongkamol C, Chintrakul A, Horsiritham K, Kiranantawat N, Nirattisaikul S, Sungsiri J, Sathirapanya P, Sathirapanya C, Boonma K, Chowwanapoonpohn T, Nuiman P, Supunthuchaikul J, Chokthamangoon N, Chintana C, Suktaneekul T, Watcharanimit C. Kongkamol C, et al. Front Public Health. 2024 Apr 9;12:1360986. doi: 10.3389/fpubh.2024.1360986. eCollection 2024. Front Public Health. 2024. PMID: 38660360 Free PMC article.

56

Antibiotic treatment modestly reduces protection against Mycobacterium tuberculosis reinfection in macaques.

Ganchua SK, Maiello P, Chao M, Hopkins F, Mugahid D, Lin PL, Fortune SM, Flynn JL. Ganchua SK, et al. Infect Immun. 2024 Apr 9;92(4):e0053523. doi: 10.1128/iai.00535-23. Epub 2024 Mar 22. Infect Immun. 2024. PMID: 38514467 Free PMC article.

57

Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting.

Park Y, Tung PM, Anh NK, Cho YS, Shin JG. Park Y, et al. J Korean Med Sci. 2024 Apr 8;39(13):e104. doi: 10.3346/jkms.2024.39.e104. J Korean Med Sci. 2024. PMID: 38599596 Free PMC article.

58

Short-duration treatment for latent tuberculosis in migrants: VDOT monitoring in Manaus, AM.

Alves YM, Jesuz SV, Berra TZ, Araújo VMS, Maciel ELN, Arcêncio RA. Alves YM, et al. Rev Soc Bras Med Trop. 2024 Apr 5;57:e00602. doi: 10.1590/0037-8682-0530-2023. eCollection 2024. Rev Soc Bras Med Trop. 2024. PMID: 38597524 Free PMC article. No abstract available.

59

Development of a multiplex droplet digital PCR method for detection and monitoring of Mycobacterium tuberculosis and drug-resistant tuberculosis.

Choi YJ, Kim Y, Park HJ, Kim D, Lee H, Kim YA, Lee KA. Choi YJ, et al. Ann Clin Microbiol Antimicrob. 2024 Apr 5;23(1):29. doi: 10.1186/s12941-024-00687-2. Ann Clin Microbiol Antimicrob. 2024. PMID: 38581051 Free PMC article.

60

The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova.

Chitwood MH, Colijn C, Yang C, Crudu V, Ciobanu N, Codreanu A, Kim J, Rancu I, Rhee K, Cohen T, Sobkowiak B. Chitwood MH, et al. Nat Commun. 2024 Apr 5;15(1):2962. doi: 10.1038/s41467-024-47282-9. Nat Commun. 2024. PMID: 38580642 Free PMC article.

61

Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy.

Chen HW, Kuo YW, Chen CY, Chang CH, Wang SM, Chien YC, Lu WC, Chen JP, Chang CY, Wei YF, Chang SC, Shu CC, Wang JY, Liao WY, Wang HC, Yu CJ. Chen HW, et al. Oncologist. 2024 Apr 4;29(4):e498-e506. doi: 10.1093/oncolo/oyad340. Oncologist. 2024. PMID: 38227604 Free PMC article.

62

Gendered gaps to tuberculosis prevention and care in Kenya: a political economy analysis study.

Abdullahi LH, Oketch S, Komen H, Mbithi I, Millington K, Mulupi S, Chakaya J, Zulu EM. Abdullahi LH, et al. BMJ Open. 2024 Apr 3;14(4):e077989. doi: 10.1136/bmjopen-2023-077989. BMJ Open. 2024. PMID: 38569714 Free article.

63

Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MIC.

Villellas C, Stevenaert F, Remmerie B, Andries K. Villellas C, et al. Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0127523. doi: 10.1128/aac.01275-23. Epub 2024 Mar 12. Antimicrob Agents Chemother. 2024. PMID: 38470194 Free PMC article.

64

Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis.

Olivença F, Pires D, Silveiro C, Gama B, Holtreman F, Anes E, Catalão MJ. Olivença F, et al. Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0158623. doi: 10.1128/aac.01586-23. Epub 2024 Feb 27. Antimicrob Agents Chemother. 2024. PMID: 38411952 Free PMC article.

65

Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.

Li S-Y, Tyagi S, Soni H, Betoudji F, Converse PJ, Mdluli K, Upton AM, Fotouhi N, Barros-Aguirre D, Ballell L, Jimenez-Navarro E, Nuermberger EL. Li S-Y, et al. Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0156223. doi: 10.1128/aac.01562-23. Epub 2024 Feb 20. Antimicrob Agents Chemother. 2024. PMID: 38376228 Free PMC article.

66

Towards universal health coverage in Vietnam: a mixed-method case study of enrolling people with tuberculosis into social health insurance.

Forse R, Yoshino CA, Nguyen TT, Phan THY, Vo LNQ, Codlin AJ, Nguyen L, Hoang C, Basu L, Pham M, Nguyen HB, Van Dinh L, Caws M, Wingfield T, Lönnroth K, Sidney-Annerstedt K. Forse R, et al. Health Res Policy Syst. 2024 Apr 2;22(1):40. doi: 10.1186/s12961-024-01132-8. Health Res Policy Syst. 2024. PMID: 38566224 Free PMC article.

67

The plasma kynurenine-to-tryptophan ratio as a biomarker of tuberculosis disease in people living with HIV on antiretroviral therapy: an exploratory nested case-control study.

Gatechompol S, Lutter R, Vaz FM, Ubolyam S, Avihingsanon A, Kerr SJ, van Leth F, Cobelens F. Gatechompol S, et al. BMC Infect Dis. 2024 Apr 2;24(1):372. doi: 10.1186/s12879-024-09258-4. BMC Infect Dis. 2024. PMID: 38565993 Free PMC article.

68

Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta Town, Northwest Ethiopia: a five-year retrospective study.

Limenh LW, Kasahun AE, Sendekie AK, Seid AM, Mitku ML, Fenta ET, Melese M, Workye M, Simegn W, Ayenew W. Limenh LW, et al. Sci Rep. 2024 Apr 2;14(1):7695. doi: 10.1038/s41598-024-58080-0. Sci Rep. 2024. PMID: 38565912 Free PMC article.

69

Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini.

Peresu E, De Graeve D, Heunis JC, Kigozi NG. Peresu E, et al. PLoS One. 2024 Apr 2;19(4):e0301507. doi: 10.1371/journal.pone.0301507. eCollection 2024. PLoS One. 2024. PMID: 38564589 Free PMC article.

70

The Impact of Optimal Glycemic Control on Tuberculosis Treatment Outcomes in Patients With Diabetes Mellitus: Systematic Review and Meta-Analysis.

Zhao L, Gao F, Zheng C, Sun X. Zhao L, et al. JMIR Public Health Surveill. 2024 Apr 2;10:e53948. doi: 10.2196/53948. JMIR Public Health Surveill. 2024. PMID: 38564244 Free PMC article. Review.

71

The Titanic question in TB control: Should we worry about the bummock?

Fortune SM. Fortune SM. Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2403321121. doi: 10.1073/pnas.2403321121. Epub 2024 Mar 25. Proc Natl Acad Sci U S A. 2024. PMID: 38527210 Free PMC article. No abstract available.

72

Effect of smoking cessation interventions on abstinence and tuberculosis treatment outcomes among newly diagnosed patients: a randomized controlled trial.

Khan MT, Zaheer S, Amar W, Shafique K. Khan MT, et al. Microbiol Spectr. 2024 Apr 2;12(4):e0387823. doi: 10.1128/spectrum.03878-23. Epub 2024 Feb 22. Microbiol Spectr. 2024. PMID: 38385711 Free article. Clinical Trial.

73

Why do we use 100 mg of clofazimine in TB and NTM treatment?

van Ingen J. van Ingen J. J Antimicrob Chemother. 2024 Apr 2;79(4):697-702. doi: 10.1093/jac/dkae041. J Antimicrob Chemother. 2024. PMID: 38385505 Free PMC article. Review.

74

Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication.

Ozsoy Z, Ayan G, Durhan G, Kalyoncu U. Ozsoy Z, et al. Rheumatology (Oxford). 2024 Apr 2;63(4):1147-1152. doi: 10.1093/rheumatology/kead361. Rheumatology (Oxford). 2024. PMID: 37498613 Free PMC article.

75

Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023.

Otto-Knapp R, Edwards S, Kuchukhidze G, Kröger S, Häcker B, Bivol S, Yedilbayev A. Otto-Knapp R, et al. Euro Surveill. 2024 Apr;29(17). doi: 10.2807/1560-7917.ES.2024.29.17.2400211. Euro Surveill. 2024. PMID: 38666403 Free article.

76

Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review.

Surarak T, Chumnumwat S, Nosoongnoen W, Tragulpiankit P. Surarak T, et al. Clin Transl Sci. 2024 Apr;17(4):e13795. doi: 10.1111/cts.13795. Clin Transl Sci. 2024. PMID: 38629592 Free PMC article. Review.

77

Coverage of BCG Vaccination for children aged until 7 years old and its determinants in French Guiana.

Wang Q, Nacher M, Tosi A, Clarke L, Rwagitinywa J, Alsibai KD, Castor MJ. Wang Q, et al. J Epidemiol Popul Health. 2024 Apr;72(2):202381. doi: 10.1016/j.jeph.2024.202381. Epub 2024 Apr 4. J Epidemiol Popul Health. 2024. PMID: 38579396 Free article.

78

A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT.

Gao J, Gao M, Du J, Pang Y, Mao G, Lounis N, Bakare N, Jiang Y, Zhan Y, Liu Y, Li L; Trial Team. Gao J, et al. Trials. 2024 Apr 1;25(1):227. doi: 10.1186/s13063-024-07946-9. Trials. 2024. PMID: 38561815 Free PMC article.

79

Unusual presentation of miliary tuberculosis in a 12-year-old girl: a case report.

Kamali M, Navaeifar MR, Abbaskhanian A, Hajialibeig A, Godazandeh F, Salehpour M, Rezai MS. Kamali M, et al. BMC Pediatr. 2024 Apr 1;24(1):223. doi: 10.1186/s12887-023-04427-x. BMC Pediatr. 2024. PMID: 38561744 Free PMC article.

80

Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.

Gurrey SO, Strick LB, Dov LK, Miller JS, Pecha M, Stalter RM, Miller DL, Marshall B, Salazar AP, Newman LP. Gurrey SO, et al. Emerg Infect Dis. 2024 Apr;30(13):S17-S20. doi: 10.3201/eid3013.230777. Emerg Infect Dis. 2024. PMID: 38561633 Free PMC article. Review.

81

The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia.

Chanda E. Chanda E. BMC Infect Dis. 2024 Apr 1;24(1):364. doi: 10.1186/s12879-024-09238-8. BMC Infect Dis. 2024. PMID: 38556907 Free PMC article. Review.

82

Identifying local foci of tuberculosis transmission in Moldova using a spatial multinomial logistic regression model.

Lan Y, Crudu V, Ciobanu N, Codreanu A, Chitwood MH, Sobkowiak B, Warren JL, Cohen T. Lan Y, et al. EBioMedicine. 2024 Apr;102:105085. doi: 10.1016/j.ebiom.2024.105085. Epub 2024 Mar 26. EBioMedicine. 2024. PMID: 38531172 Free PMC article.

83

Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.

Fukunaga R, Pierre P, Williams JK, Briceno-Robaugh R, Kalibala S, Peterson M, Moonan PK. Fukunaga R, et al. Emerg Infect Dis. 2024 Apr;30(4):1-5. doi: 10.3201/eid3004.231726. Emerg Infect Dis. 2024. PMID: 38526190 Free PMC article.

84

Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022.

Dahl VN, Butova T, Rosenthal A, Grinev A, Gabrielian A, Vashakidze S, Shubladze N, Toxanbayeva B, Chingissova L, Crudu V, Chesov D, Kalmambetova G, Saparova G, Wejse CM, Butov D; Ukraine TB-Portal Study Group. Dahl VN, et al. Emerg Infect Dis. 2024 Apr;30(4):831-833. doi: 10.3201/eid3004.231732. Emerg Infect Dis. 2024. PMID: 38526186 Free PMC article.

85

Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis.

Eckartt KA, Delbeau M, Munsamy-Govender V, DeJesus MA, Azadian ZA, Reddy AK, Chandanani J, Poulton NC, Quiñones-Garcia S, Bosch B, Landick R, Campbell EA, Rock JM. Eckartt KA, et al. Nature. 2024 Apr;628(8006):186-194. doi: 10.1038/s41586-024-07206-5. Epub 2024 Mar 20. Nature. 2024. PMID: 38509362 Free PMC article.

86

Screening for latent tuberculosis in migrants-status quo and future challenges.

Petersen E, Al-Abri S, Al-Jardani A, Memish ZA, Aklillu E, Ntoumi F, Mwaba P, Wejse C, Zumla A, Al-Yaquobi F. Petersen E, et al. Int J Infect Dis. 2024 Apr;141S:107002. doi: 10.1016/j.ijid.2024.107002. Epub 2024 Mar 11. Int J Infect Dis. 2024. PMID: 38479577 Free article. Review.

87

World Tuberculosis Day 2024 theme "Yes! We can end TB" can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease.

Goletti D, Al-Abri S, Migliori GB, Arlehamn CL, Haldar P, Sundling C, da Costa C, To KW, Martineau AR, Petersen E, Zumla A, Shan Lee S. Goletti D, et al. Int J Infect Dis. 2024 Apr;141S:106993. doi: 10.1016/j.ijid.2024.106993. Epub 2024 Mar 7. Int J Infect Dis. 2024. PMID: 38458422 Free article. No abstract available.

88

Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB/RIF Ultra, and culture in Uganda.

Musisi E, Wamutu S, Ssengooba W, Kasiinga S, Sessolo A, Sanyu I, Kaswabuli S, Zawedde J, Byanyima P, Kia P, Muwambi W, Toskin DT, Kigozi E, Walbaum N, Dombay E, Legrady MB, Ssemambo KD, Joloba M, Kuchaka D, Worodria W, Huang L, Gillespie SH, Sabiiti W. Musisi E, et al. Lancet Microbe. 2024 Apr;5(4):e345-e354. doi: 10.1016/S2666-5247(23)00367-1. Epub 2024 Mar 5. Lancet Microbe. 2024. PMID: 38458206 Free article.

89

Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM).

Brinkmann F, Friedrichs A, Behrens GM, Behrens P, Berner R, Caliebe A, Denkinger CM, Giesbrecht K, Gussew A, Hoffmann AT, Hojenski L, Hovardovska O, Dopfer-Jablonka A, Kaasch AJ, Kobbe R, Kraus M, Lindner A, Maier C, Mitrov L, Nauck M, de Miranda SN, Scherer M, Schmiedel Y, Stahl D, Timmesfeld N, Toepfner N, Vehreschild J, Wohlgemuth WA, Petersmann A, Vehreschild MJGT; NU(M)KRAINE Study Group. Brinkmann F, et al. J Infect Public Health. 2024 Apr;17(4):642-649. doi: 10.1016/j.jiph.2024.02.003. Epub 2024 Feb 16. J Infect Public Health. 2024. PMID: 38458134 Free article.

90

Predictors, mortality, and health outcomes of intensive phase non-adherence to a regimen in patients with drug-susceptible tuberculosis: a nationwide linkage database.

Lee H, Bea S, Kim JH, Jeong HE, Jang SH, Son H, Shin JY. Lee H, et al. Public Health. 2024 Apr;229:167-175. doi: 10.1016/j.puhe.2024.01.021. Epub 2024 Mar 6. Public Health. 2024. PMID: 38452561 Free article.

91

Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis.

Zhang F, Zhang F, Li L, Pang Y. Zhang F, et al. J Infect Public Health. 2024 Apr;17(4):632-641. doi: 10.1016/j.jiph.2024.02.012. Epub 2024 Feb 23. J Infect Public Health. 2024. PMID: 38428275 Free article. Review.

92

From antigens to immune responses: Shaping the future of TB detection and prevention.

Panda S, Kearns K, Cheng C, Lindestam Arlehamn CS. Panda S, et al. Int J Infect Dis. 2024 Apr;141S:106983. doi: 10.1016/j.ijid.2024.106983. Epub 2024 Feb 26. Int J Infect Dis. 2024. PMID: 38417617 Free article. Review.

93

Canine tuberculosis: A review of 18 new and 565 previously reported confirmed cases.

O'Halloran C, Barker EN, Hope JC, Gunn-Moore DA. O'Halloran C, et al. Vet J. 2024 Apr;304:106089. doi: 10.1016/j.tvjl.2024.106089. Epub 2024 Feb 25. Vet J. 2024. PMID: 38412886 Free article. Review.

94

A systematic efficacy analysis of tuberculosis treatment with BPaL-containing regimens using a multiscale modeling approach.

Budak M, Via LE, Weiner DM, Barry CE 3rd, Nanda P, Michael G, Mdluli K, Kirschner D. Budak M, et al. CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):673-685. doi: 10.1002/psp4.13117. Epub 2024 Feb 26. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38404200 Free PMC article.

95

PASS to End TB in Europe: Accelerated efforts on prevention and systematic screening to end tuberculosis in the WHO European Region by 2030.

Dadu A, Yedilbayev A, Migliori GB, Ahmedov S, Falzon D, den Boon S, Kanchar A, Matteelli A. Dadu A, et al. Int J Infect Dis. 2024 Apr;141S:106980. doi: 10.1016/j.ijid.2024.02.023. Epub 2024 Feb 23. Int J Infect Dis. 2024. PMID: 38403111 Free article.

96

Incidence of tuberculosis disease in individuals diagnosed with tuberculosis infection after screening: A population-based cohort study in South Korea.

Lee J, Kim D, Hwang J, Kwon JW. Lee J, et al. Int J Infect Dis. 2024 Apr;141:106961. doi: 10.1016/j.ijid.2024.02.004. Epub 2024 Feb 8. Int J Infect Dis. 2024. PMID: 38340783 Free article.

97

Phase 2 trial of a novel tuberculosis drug launched.

Holt E. Holt E. Lancet Microbe. 2024 Apr;5(4):e316. doi: 10.1016/S2666-5247(23)00401-9. Epub 2024 Jan 9. Lancet Microbe. 2024. PMID: 38215765 Free article. Clinical Trial. No abstract available.

98

Tuberculosis treatment monitoring tests during routine practice: study design guidance.

MacLean EL, Zimmer AJ, den Boon S, Gupta-Wright A, Cirillo DM, Cobelens F, Gillespie SH, Nahid P, Phillips PP, Ruhwald M, Denkinger CM. MacLean EL, et al. Clin Microbiol Infect. 2024 Apr;30(4):481-488. doi: 10.1016/j.cmi.2023.12.027. Epub 2024 Jan 3. Clin Microbiol Infect. 2024. PMID: 38182047 Free article.

99

Knowledge, attitudes, and practice toward tuberculosis in high school students in Qingdao, China.

Dai X, Li S, Song S, Chen M, Xu H, Li X, Zhang M, Zhang H, Sun H, Wang Z. Dai X, et al. J Infect Dev Ctries. 2024 Mar 31;18(3):427-434. doi: 10.3855/jidc.18312. J Infect Dev Ctries. 2024. PMID: 38635618 Free article.

100

Estimation of country-specific tuberculosis resistance antibiograms using pathogen genomics and machine learning.

Dixit A, Freschi L, Vargas R, Gröschel MI, Nakhoul M, Tahseen S, Alam SMM, Kamal SMM, Skrahina A, Basilio RP, Lim DR, Ismail N, Farhat MR. Dixit A, et al. BMJ Glob Health. 2024 Mar 28;9(3):e013532. doi: 10.1136/bmjgh-2023-013532. BMJ Glob Health. 2024. PMID: 38548342 Free PMC article.

101

Tuberculosis - United States, 2023.

Williams PM, Pratt RH, Walker WL, Price SF, Stewart RJ, Feng PI. Williams PM, et al. MMWR Morb Mortal Wkly Rep. 2024 Mar 28;73(12):265-270. doi: 10.15585/mmwr.mm7312a4. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38547024 Free PMC article.

102

Prevalence and risk factors of anxiety and depression in patients with multi-drug/rifampicin-resistant tuberculosis.

Dan-Ni Z, Guang-Min Z, Yu-Hua D, Ying L, Ting W, Yuan-Yuan C, Yu-Hong X, Xin-Cai X. Dan-Ni Z, et al. Front Public Health. 2024 Mar 27;12:1372389. doi: 10.3389/fpubh.2024.1372389. eCollection 2024. Front Public Health. 2024. PMID: 38601494 Free PMC article.

103

Progress and challenges in achieving tuberculosis elimination in India by 2025: A systematic review and meta-analysis.

Padhi A, Agarwal A, Bhise M, Chaudhary A, Joshi K, Katoch CDS. Padhi A, et al. PLoS One. 2024 Mar 27;19(3):e0301060. doi: 10.1371/journal.pone.0301060. eCollection 2024. PLoS One. 2024. PMID: 38536792 Free PMC article.

104

Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review.

Sodré-Alves BMC, Toledo MM, Zimmermann IR, Araújo WN, Tavares NUL. Sodré-Alves BMC, et al. Rev Soc Bras Med Trop. 2024 Mar 25;57:e004022024. doi: 10.1590/0037-8682-0504-2023. eCollection 2024. Rev Soc Bras Med Trop. 2024. PMID: 38536998 Free PMC article.

105

Is convenience really king? Comparative evaluation of catastrophic costs due to tuberculosis in the public and private healthcare sectors of Viet Nam: a longitudinal patient cost study.

Nguyen HB, Vo LNQ, Forse RJ, Wiemers AMC, Huynh HB, Dong TTT, Phan YTH, Creswell J, Dang TMH, Nguyen LH, Shedrawy J, Lönnroth K, Nguyen TD, Dinh LV, Annerstedt KS, Codlin AJ. Nguyen HB, et al. Infect Dis Poverty. 2024 Mar 25;13(1):27. doi: 10.1186/s40249-024-01196-2. Infect Dis Poverty. 2024. PMID: 38528604 Free PMC article.

106

Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis.

Le X, Shen Y. Le X, et al. Viruses. 2024 Mar 23;16(4):494. doi: 10.3390/v16040494. Viruses. 2024. PMID: 38675837 Free PMC article. Review.

107

Multidrug-resistant Mycobacterium tuberculosis transmission in Shandong, China.

Li Y, Li Y, Wang T, Li Y, Tao N, Kong X, Zhang Y, Han Q, Liu Y, Li H. Li Y, et al. Medicine (Baltimore). 2024 Mar 22;103(12):e37617. doi: 10.1097/MD.0000000000037617. Medicine (Baltimore). 2024. PMID: 38518003 Free PMC article.

108

Acute ischemic stroke in tuberculous meningitis.

Guo YJ, Gan XL, Zhang RY, Liu Y, Wang EL, Lu SH, Jiang H, Duan HF, Yuan ZZ, Li WM. Guo YJ, et al. Front Public Health. 2024 Mar 21;12:1362465. doi: 10.3389/fpubh.2024.1362465. eCollection 2024. Front Public Health. 2024. PMID: 38577289 Free PMC article.

109

Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.

Emani S, Alves K, Alves LC, da Silva DA, Oliveira PB, Castro MC, Cohen T, Couto RM, Sanchez M, Menzies NA. Emani S, et al. PLoS Med. 2024 Mar 21;21(3):e1004361. doi: 10.1371/journal.pmed.1004361. eCollection 2024 Mar. PLoS Med. 2024. PMID: 38512968 Free PMC article.

110

Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023.

Ajiboye AS, O'Connor S, Smith JP, Ahmedov S, Coggin WL, Charles M, Ghosh S, Pierre P, Shah N, Teran RA, Moonan PK, Date A. Ajiboye AS, et al. MMWR Morb Mortal Wkly Rep. 2024 Mar 21;73(11):233-238. doi: 10.15585/mmwr.mm7311a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38512767 Free PMC article.

111

IL-10 and TGF-β1 may weaken the efficacy of preoperative anti-tuberculosis therapy in older patients with spinal tuberculosis.

Li S, Wu R, Feng M, Zhang H, Liu D, Wang F, Chen W. Li S, et al. Front Cell Infect Microbiol. 2024 Mar 20;14:1361326. doi: 10.3389/fcimb.2024.1361326. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38572322 Free PMC article.

112

Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.

White YN, Solans BP, Denti P, van der Laan LE, Schaaf HS, Vonasek B, Malik AA, Draper HR, Hussain H, Hesseling AC, Garcia-Prats AJ, Savic RM. White YN, et al. Clin Infect Dis. 2024 Mar 20;78(3):756-764. doi: 10.1093/cid/ciae024. Clin Infect Dis. 2024. PMID: 38340060 Free PMC article.

113

The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis.

Hasan T, Medcalf E, Nyang'wa BT, Egizi E, Berry C, Dodd M, Foraida S, Gegia M, Li M, Mirzayev F, Morgan H, Motta I, Nguyen L, Schumacher S, Schlub T, Fox G. Hasan T, et al. Clin Infect Dis. 2024 Mar 20;78(3):730-741. doi: 10.1093/cid/ciad653. Clin Infect Dis. 2024. PMID: 37874021 Free PMC article. Review.

114

Patterns and profiles of drug resistance-conferring mutations in Mycobacterium tuberculosis genotypes isolated from tuberculosis-suspected attendees of spiritual holy water sites in Northwest Ethiopia.

Reta MA, Maningi NE, Fourie PB. Reta MA, et al. Front Public Health. 2024 Mar 19;12:1356826. doi: 10.3389/fpubh.2024.1356826. eCollection 2024. Front Public Health. 2024. PMID: 38566794 Free PMC article.

115

Operational priorities for engaging with India's private healthcare sector for the control of tuberculosis: a modelling study.

Ricks S, Singh A, Sodhi R, Pal A, Arinaminpathy N. Ricks S, et al. BMJ Open. 2024 Mar 19;14(3):e069304. doi: 10.1136/bmjopen-2022-069304. BMJ Open. 2024. PMID: 38508628 Free PMC article.

116

The challenges in diagnosing isolated epididymal tuberculosis (TB) in an adolescent male: a case report.

Cesilia C, Nugraha HG, Siregar S, Nataprawira HM. Cesilia C, et al. BMC Urol. 2024 Mar 19;24(1):61. doi: 10.1186/s12894-024-01442-7. BMC Urol. 2024. PMID: 38504239 Free PMC article.

117

Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021.

Jackson S, Kabir Z, Comiskey C. Jackson S, et al. Vaccine. 2024 Mar 19;42(8):2099-2105. doi: 10.1016/j.vaccine.2024.02.061. Epub 2024 Feb 29. Vaccine. 2024. PMID: 38423810 Free article.

118

Roadmap for ending TB in China by 2035: The challenges and strategies.

Feng Q, Zhang G, Chen L, Wu H, Yang Y, Gao Q, Asakawa T, Zhao Y, Lu S, Zhou L, Lu H. Feng Q, et al. Biosci Trends. 2024 Mar 19;18(1):11-20. doi: 10.5582/bst.2023.01325. Epub 2024 Feb 8. Biosci Trends. 2024. PMID: 38325824 Free article.

119

Impact of delayed diagnosis and treatment on tuberculosis infection within families: A case report.

Liu JJ, Feng YP, Liu ZD, Guo J. Liu JJ, et al. Medicine (Baltimore). 2024 Mar 15;103(11):e37406. doi: 10.1097/MD.0000000000037406. Medicine (Baltimore). 2024. PMID: 38489738 Free PMC article.

120

Discovery of 2,9-diaryl-6-carbamoylpurines as a novel class of antitubercular agents.

Correia C, Leite AC, Fraga AG, Proença MF, Pedrosa J, Carvalho MA. Correia C, et al. Eur J Med Chem. 2024 Mar 15;268:116297. doi: 10.1016/j.ejmech.2024.116297. Epub 2024 Mar 2. Eur J Med Chem. 2024. PMID: 38458108 Free article.

121

Engagement of private health care facilities in TB management in Lusaka district of Zambia: lessons learned and achievements.

Hambwalula R, Kagujje M, Mwaba I, Musonda D, Singini D, Mutti L, Sanjase N, Kaumba PC, Ziko LM, Zimba KM, Kasese-Chanda P, Muyoyeta M. Hambwalula R, et al. BMC Public Health. 2024 Mar 14;24(1):811. doi: 10.1186/s12889-024-18285-4. BMC Public Health. 2024. PMID: 38486212 Free PMC article.

122

C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay.

Russomando G, Sanabria D, Díaz Acosta CC, Rojas L, Franco L, Arenas R, Delogu G, Ndiaye MDB, Bayaa R, Rakotosamimanana N, Goletti D, Hoffmann J. Russomando G, et al. Front Immunol. 2024 Mar 13;15:1308015. doi: 10.3389/fimmu.2024.1308015. eCollection 2024. Front Immunol. 2024. PMID: 38545118 Free PMC article.

123

Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis.

Vega V, Cabrera-Sanchez J, Rodríguez S, Verdonck K, Seas C, Otero L, Van der Stuyft P. Vega V, et al. BMJ Open Respir Res. 2024 Mar 13;11(1):e002281. doi: 10.1136/bmjresp-2023-002281. BMJ Open Respir Res. 2024. PMID: 38479821 Free PMC article.

124

The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.

Cunha R, Filho DBM, M Albuquerque MFP, Lacerda HR, Diniz GTN, Montarroyos UR, Rodrigues LC, Vilela Moura LCR, Ximenes RAA. Cunha R, et al. PLoS One. 2024 Mar 13;19(3):e0299244. doi: 10.1371/journal.pone.0299244. eCollection 2024. PLoS One. 2024. PMID: 38478483 Free PMC article.

125

Knowledge, attitude, and practice toward tuberculosis prevention and management among household contacts in Suzhou Hospital, Jiangsu province, China.

Zhang Y, Wu J, Hui X, Zhang P, Xue F. Zhang Y, et al. Front Public Health. 2024 Mar 12;12:1249971. doi: 10.3389/fpubh.2024.1249971. eCollection 2024. Front Public Health. 2024. PMID: 38532970 Free PMC article.

126

Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.

Weir IR, Dufault SM, Phillips PPJ. Weir IR, et al. Trials. 2024 Mar 12;25(1):180. doi: 10.1186/s13063-024-07999-w. Trials. 2024. PMID: 38468320 Free PMC article.

127

Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review.

Dretzke J, Hobart C, Basu A, Ahyow L, Nagasivam A, Moore DJ, Gajraj R, Roy A. Dretzke J, et al. BMJ Open. 2024 Mar 11;14(3):e080827. doi: 10.1136/bmjopen-2023-080827. BMJ Open. 2024. PMID: 38471682 Free PMC article. Review.

128

Extrapulmonary, Chronic Septic Arthritis From Mycobacterium tuberculosis in the Ankle and Subtalar Joints.

Compton T, Ferguson NA, Certain L, Nixon D. Compton T, et al. J Am Acad Orthop Surg Glob Res Rev. 2024 Mar 11;8(3):e23.00273. doi: 10.5435/JAAOSGlobal-D-23-00273. eCollection 2024 Mar 1. J Am Acad Orthop Surg Glob Res Rev. 2024. PMID: 38466986 Free PMC article.

129

Knowledge, attitudes, and practices towards childhood tuberculosis among healthcare workers at two primary health facilities in Lusaka, Zambia.

Kaumba PC, Siameka D, Kagujje M, Chungu C, Nyangu S, Sanjase N, Maimbolwa MM, Shuma B, Chilukutu L, Muyoyeta M. Kaumba PC, et al. PLoS One. 2024 Mar 11;19(3):e0287876. doi: 10.1371/journal.pone.0287876. eCollection 2024. PLoS One. 2024. PMID: 38466675 Free PMC article.

130

Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.

Yang F, Labani-Motlagh A, Bohorquez JA, Moreira JD, Ansari D, Patel S, Spagnolo F, Florence J, Vankayalapati A, Sakai T, Sato O, Ikebe M, Vankayalapati R, Dennehy JJ, Samten B, Yi G. Yang F, et al. Commun Biol. 2024 Mar 9;7(1):294. doi: 10.1038/s42003-024-06006-x. Commun Biol. 2024. PMID: 38461214 Free PMC article.

131

Mid-level managers' perspectives on implementing isoniazid preventive therapy for people living with HIV in Ugandan health districts: a qualitative study.

Christian C, Kakande E, Nahurira V, Akatukwasa C, Atwine F, Bakanoma R, Itiakorit H, Owaraganise A, DiIeso W, Rast D, Kabami J, Peretz JJ, Shade SB, Kamya MR, Havlir DV, Chamie G, Camlin CS. Christian C, et al. BMC Health Serv Res. 2024 Mar 8;24(1):313. doi: 10.1186/s12913-024-10803-9. BMC Health Serv Res. 2024. PMID: 38454501 Free PMC article.

132

The collaborative framework for the management of tuberculosis and type 2 diabetes syndemic in low- and middle-income countries: a rapid review.

Milice DM, Macicame I, L Peñalvo J. Milice DM, et al. BMC Public Health. 2024 Mar 7;24(1):738. doi: 10.1186/s12889-024-18256-9. BMC Public Health. 2024. PMID: 38454428 Free PMC article. Review.

133

The prevalence, clinical reasoning and impact of non-standard anti-tuberculosis regimens at the initial prescription.

Chen RT, Liu CY, Lin SY, Shu CC, Sheng WH. Chen RT, et al. Sci Rep. 2024 Mar 7;14(1):5631. doi: 10.1038/s41598-024-55273-5. Sci Rep. 2024. PMID: 38453976 Free PMC article.

134

Impacts of armed conflicts on tuberculosis burden and treatment outcomes: a systematic review.

Gebreyohannes EA, Wolde HF, Akalu TY, Clements ACA, Alene KA. Gebreyohannes EA, et al. BMJ Open. 2024 Mar 7;14(3):e080978. doi: 10.1136/bmjopen-2023-080978. BMJ Open. 2024. PMID: 38453196 Free PMC article.

135

Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice.

Kurtz SL, Baker RE, Boehm FJ, Lehman CC, Mittereder LR, Khan H, Rossi AP, Gatti DM, Beamer G, Sassetti CM, Elkins KL. Kurtz SL, et al. PLoS Pathog. 2024 Mar 7;20(3):e1012069. doi: 10.1371/journal.ppat.1012069. eCollection 2024 Mar. PLoS Pathog. 2024. PMID: 38452145 Free PMC article.

136

Epidemiology of and programmatic response to tuberculosis in Solomon Islands: analysis of surveillance data, 2016-2022.

Yanagawa M, Gwali B, Kako H, Itogo N, Tanabose L, Morishita F. Yanagawa M, et al. Western Pac Surveill Response J. 2024 Mar 6;15(1):1-10. doi: 10.5365/wpsar.2024.15.1.1106. eCollection 2024 Jan-Mar. Western Pac Surveill Response J. 2024. PMID: 38562912 Free PMC article.

137

Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid.

Rupasinghe P, Reenaers R, Vereecken J, Mulders W, Cogneau S, Merker M, Niemann S, Vally Omar S, Rigouts L, Köser CU, Decroo T, de Jong BC. Rupasinghe P, et al. Microbiol Spectr. 2024 Mar 5;12(3):e0007024. doi: 10.1128/spectrum.00070-24. Epub 2024 Feb 9. Microbiol Spectr. 2024. PMID: 38334384 Free PMC article.

138

Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.

Prommi A, Wongjarit K, Petsong S, Somsukpiroh U, Faksri K, Kawkitinarong K, Payungporn S, Rotcheewaphan S. Prommi A, et al. Microbiol Spectr. 2024 Mar 5;12(3):e0346223. doi: 10.1128/spectrum.03462-23. Epub 2024 Feb 7. Microbiol Spectr. 2024. PMID: 38323824 Free PMC article.

139

A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors.

Smiejkowska N, Oorts L, Van Calster K, De Vooght L, Geens R, Mattelaer H-P, Augustyns K, Strelkov SV, Lamprecht D, Temmerman K, Sterckx YG-J, Cappoen D, Cos P. Smiejkowska N, et al. Microbiol Spectr. 2024 Mar 5;12(3):e0372323. doi: 10.1128/spectrum.03723-23. Epub 2024 Feb 5. Microbiol Spectr. 2024. PMID: 38315026 Free PMC article.

140

Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone.

Blankson HNA, Kamara RF, Barilar I, Andres S, Conteh OS, Dallenga T, Foray L, Maurer F, Kranzer K, Utpatel C, Niemann S. Blankson HNA, et al. Microbiol Spectr. 2024 Mar 5;12(3):e0240523. doi: 10.1128/spectrum.02405-23. Epub 2024 Jan 30. Microbiol Spectr. 2024. PMID: 38289066 Free PMC article.

141

Drug-resistant tuberculosis is a global cause of concern.

Pedersen OS, Rudolf F, Johansen IS, Andersen ÅB, Lillebæk T, Wejse CM, Dahl VN. Pedersen OS, et al. Ugeskr Laeger. 2024 Mar 4;186(10):V11230698. doi: 10.61409/V11230698. Ugeskr Laeger. 2024. PMID: 38445341 Free article. Review. Danish.

142

Diagnosis of multiple tuberculous muscle abscesses in a patient with systemic lupus erythematosus by metagenomic next-generation sequencing- a case report and literature review.

Wentao L, Shuxia X, Guoxing Z, Qiaoping C, Peiran C, Angela W, Meirong L, Songchao Y, Peiying F. Wentao L, et al. BMC Infect Dis. 2024 Mar 4;24(1):284. doi: 10.1186/s12879-024-09179-2. BMC Infect Dis. 2024. PMID: 38438834 Free PMC article. Review.

143

Multi-platform whole genome sequencing for tuberculosis clinical and surveillance applications.

Thorpe J, Sawaengdee W, Ward D, Campos M, Wichukchinda N, Chaiyasirinroje B, Thanraka A, Chumpol J, Phelan JE, Campino S, Mahasirimongkol S, Clark TG. Thorpe J, et al. Sci Rep. 2024 Mar 3;14(1):5201. doi: 10.1038/s41598-024-55865-1. Sci Rep. 2024. PMID: 38431684 Free PMC article.

144

Managing Hepatotoxicity Caused by Anti-tuberculosis Drugs: A Comparative Study of Approaches.

Abbaspour F, Hasannezhad M, Khalili H, SeyedAlinaghi S, Jafari S. Abbaspour F, et al. Arch Iran Med. 2024 Mar 1;27(3):122-126. doi: 10.34172/aim.2024.19. Arch Iran Med. 2024. PMID: 38685836 Free article.

145

Interventions to Improve Adherence to Medication on Multidrug-Resistant Tuberculosis Patients: A Scoping Review.

Octaviani P, Ikawati Z, Yasin NM, Kristina SA, Kusuma IY. Octaviani P, et al. Med J Malaysia. 2024 Mar;79(2):212-221. Med J Malaysia. 2024. PMID: 38553929 Free article. Review.

146

Cost-effectiveness of active tuberculosis screening among high-risk populations in low tuberculosis incidence countries: a systematic review, 2008 to 2023.

Gogichadze N, Sagrera A, Vicente JÁ, Millet JP, López-Seguí F, Vilaplana C. Gogichadze N, et al. Euro Surveill. 2024 Mar;29(12). doi: 10.2807/1560-7917.ES.2024.29.12.2300614. Euro Surveill. 2024. PMID: 38516785 Free article.

147

Perioperative nutrition management in patients with spinal tuberculosis taking ERAS measures.

Ma J, Li Z, Chen Y, Zhang Y, Wang Q, Yan G, Dong W, Li S. Ma J, et al. Asia Pac J Clin Nutr. 2024 Mar;33(1):39-46. doi: 10.6133/apjcn.202403_34(1).0005. Asia Pac J Clin Nutr. 2024. PMID: 38494686 Free article. Clinical Trial.

148

Exploring the Potential of Exosomes as Biomarkers in Tuberculosis and Other Diseases.

Arya R, Jit BP, Kumar V, Kim JJ. Arya R, et al. Int J Mol Sci. 2024 Mar 1;25(5):2885. doi: 10.3390/ijms25052885. Int J Mol Sci. 2024. PMID: 38474139 Free PMC article. Review.

149

Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients.

Choi WI. Choi WI. Korean J Intern Med. 2024 Mar;39(2):203-204. doi: 10.3904/kjim.2024.031. Epub 2024 Feb 28. Korean J Intern Med. 2024. PMID: 38444063 Free PMC article. No abstract available.

150

Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27^-CD38⁺IFN-γ⁺CD4⁺ T cells before and after anti-tuberculosis treatment.

Fang Y, Tang Y, Luo QX, Wang N, Tang L, Yang XJ, You XF, Wang YC, Liang L, Zhang JB, Su B, Sha W. Fang Y, et al. Eur J Med Res. 2024 Mar 1;29(1):147. doi: 10.1186/s40001-024-01713-x. Eur J Med Res. 2024. PMID: 38429734 Free PMC article.

151

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity.

Yoon JG, Jang DG, Cho SG, Lee C, Noh SH, Seo SK, Yu JW, Chung HW, Han K, Kwon SS, Han DH, Oh J, Jang IJ, Kim SH, Jee YK, Lee H, Park DW, Sohn JW, Yoon HJ, Kim CH, Lee JM, Kim SH, Lee MG. Yoon JG, et al. Exp Mol Med. 2024 Mar;56(3):570-582. doi: 10.1038/s12276-024-01172-8. Epub 2024 Mar 1. Exp Mol Med. 2024. PMID: 38424191 Free PMC article.

152

Tuberculosis contact tracing, Angola.

Martínez-Campreciós J, Gil E, Aixut S, Moreno M, Zacarias A, Nindia A, Gabriel E, Espinosa-Pereiro J, Sánchez-Montalvá A, Aznar ML, Molina I. Martínez-Campreciós J, et al. Bull World Health Organ. 2024 Mar 1;102(3):196-203. doi: 10.2471/BLT.23.290068. Epub 2024 Jan 31. Bull World Health Organ. 2024. PMID: 38420572 Free PMC article.

153

Contribution of herd management, biosecurity, and environmental factors to the risk of bovine tuberculosis in a historically low prevalence region.

Pozo P, Isla J, Asiain A, Navarro D, Gortázar C. Pozo P, et al. Animal. 2024 Mar;18(3):101105. doi: 10.1016/j.animal.2024.101105. Epub 2024 Feb 8. Animal. 2024. PMID: 38417216 Free article.

154

Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.

Günther G, Mhuulu L, Diergaardt A, Dreyer V, Moses M, Anyolo K, Ruswa N, Claassens M, Niemann S, Nepolo E. Günther G, et al. Emerg Infect Dis. 2024 Mar;30(3):568-571. doi: 10.3201/eid3003.240134. Emerg Infect Dis. 2024. PMID: 38407158 Free PMC article.

155

A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.

Diacon AH, Barry CE 3rd, Carlton A, Chen RY, Davies M, de Jager V, Fletcher K, Koh GCKW, Kontsevaya I, Heyckendorf J, Lange C, Reimann M, Penman SL, Scott R, Maher-Edwards G, Tiberi S, Vlasakakis G, Upton CM, Aguirre DB. Diacon AH, et al. Nat Med. 2024 Mar;30(3):896-904. doi: 10.1038/s41591-024-02829-7. Epub 2024 Feb 16. Nat Med. 2024. PMID: 38365949 Free PMC article. Clinical Trial.

156

Beyond tuberculosis: a person-centred and rights-based approach to screening for household contacts.

Calderwood CJ, Timire C, Mavodza C, Kavenga F, Ngwenya M, Madziva K, Fielding K, Dixon J, Ferrand RA, Kranzer K. Calderwood CJ, et al. Lancet Glob Health. 2024 Mar;12(3):e509-e515. doi: 10.1016/S2214-109X(23)00544-2. Lancet Glob Health. 2024. PMID: 38365421 Free article. Review.

157

Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study.

Chung E, Jeong D, Mok J, Jeon D, Kang HY, Kim H, Kim H, Choi H, Kang YA. Chung E, et al. Korean J Intern Med. 2024 Mar;39(2):306-317. doi: 10.3904/kjim.2023.303. Epub 2024 Feb 6. Korean J Intern Med. 2024. PMID: 38317270 Free PMC article.

158

Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation.

Min S, Kwon SH, Lee EK, Nam JH. Min S, et al. J Infect Public Health. 2024 Mar;17(3):478-485. doi: 10.1016/j.jiph.2024.01.002. Epub 2024 Jan 6. J Infect Public Health. 2024. PMID: 38271751 Free article.

159

Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study.

Torres T, Chiricozzi A, Puig L, Lé AM, Marzano AV, Dapavo P, Dauden E, Carrascosa JM, Lazaridou E, Duarte G, Carvalho AVE, Romiti R, Rompoti N, Teixeira L, Abreu M, Ippoliti E, Maronese CA, Llamas-Velasco M, Vilarrasa E, Del Alcázar E, Daponte AI, Papoutsaki M, Carugno A, Bellinato F, Gisondi P. Torres T, et al. Am J Clin Dermatol. 2024 Mar;25(2):333-342. doi: 10.1007/s40257-024-00845-4. Epub 2024 Jan 24. Am J Clin Dermatol. 2024. PMID: 38265746 Free PMC article.

160

Diagnostic accuracy of Xpert MTB/RIF Ultra for childhood tuberculosis in West Africa - a multicenter pragmatic study.

Diallo AB, Edem VF, Fiogbe A, Osman KA, Tolofoudie M, Somboro A, Diarra B, Ogunbosi B, Abok I, Ebonyi AO, Goka B, Affolabi D, Oladokun R, Kehinde AO, Mohammed N, Togun T. Diallo AB, et al. Int J Infect Dis. 2024 Mar;140:86-91. doi: 10.1016/j.ijid.2024.01.003. Epub 2024 Jan 19. Int J Infect Dis. 2024. PMID: 38244884 Free article. Clinical Trial.

161

Xpert MTB/RIF Ultra for the rapid diagnosis of extrapulmonary tuberculosis in a clinical setting of high tuberculosis prevalence country and interpretation of 'trace' results.

Nasrin R, Uddin MKM, Kabir SN, Rahman T, Biswas S, Hossain A, Rahman SMM, Ahmed S, Pouzol S, Hoffmann J, Banu S. Nasrin R, et al. Tuberculosis (Edinb). 2024 Mar;145:102478. doi: 10.1016/j.tube.2024.102478. Epub 2024 Jan 8. Tuberculosis (Edinb). 2024. PMID: 38218133 Free article.

162

Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment.

Wang S, Forsman LD, Xu C, Zhang H, Zhu Y, Shao G, Wang S, Cao J, Xiong H, Niward K, Schön T, Bruchfeld J, Zhu L, Alffenaar JW, Hu Y. Wang S, et al. Int J Infect Dis. 2024 Mar;140:62-69. doi: 10.1016/j.ijid.2024.01.001. Epub 2024 Jan 3. Int J Infect Dis. 2024. PMID: 38176643 Free article.

163

A simple posterior approach with preservation of posterior column structure for the surgical treatment of thoracolumbar spinal tuberculosis.

Chang B, Yao P, Zhang S, Li Z. Chang B, et al. Asian J Surg. 2024 Mar;47(3):1614-1615. doi: 10.1016/j.asjsur.2023.12.035. Epub 2023 Dec 19. Asian J Surg. 2024. PMID: 38114397 Free article. No abstract available.

164

Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling.

Koele SE, Dorlo TPC, Upton CM, Aarnoutse RE, Svensson EM. Koele SE, et al. CPT Pharmacometrics Syst Pharmacol. 2024 Mar;13(3):374-385. doi: 10.1002/psp4.13089. Epub 2023 Dec 15. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38102814 Free PMC article.

165

Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine.

Pedersen OS, Butova T, Kapustnyk V, Miasoiedov V, Kuzhko M, Hryshchuk L, Kornaha S, Borovok N, Raznatovska O, Fedorec A, Bogomolov A, Tkhorovskiy M, Akymenko O, Klymenko I, Kulykova O, Karpenko Z, Shapoval T, Chursina N, Kondratyuk N, Parkhomenko O, Sazonenko I, Ostrovskyy M, Makoida I, Markovtsiy L, Skryp V, Lubenko V, Hrankina N, Bondarenko L, Hlynenko V, Dahl VN, Butov D. Pedersen OS, et al. Clin Microbiol Infect. 2024 Mar;30(3):360-367. doi: 10.1016/j.cmi.2023.12.001. Epub 2023 Dec 6. Clin Microbiol Infect. 2024. PMID: 38065363 Free article.

166

Tuberculosis of the shoulder joint: A case report.

Qi Y, Yang J, Kou X, Li X. Qi Y, et al. Asian J Surg. 2024 Mar;47(3):1423-1424. doi: 10.1016/j.asjsur.2023.11.112. Epub 2023 Dec 2. Asian J Surg. 2024. PMID: 38042651 Free article. No abstract available.

167

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.

Wajja A, Nassanga B, Natukunda A, Serubanja J, Tumusiime J, Akurut H, Oduru G, Nassuuna J, Kabagenyi J, Morrison H, Scott H, Doherty RP, Marshall JL, Puig IC, Cose S, Kaleebu P, Webb EL, Satti I, McShane H, Elliott AM; TB042 Study Team. Wajja A, et al. Lancet Infect Dis. 2024 Mar;24(3):285-296. doi: 10.1016/S1473-3099(23)00501-7. Epub 2023 Nov 25. Lancet Infect Dis. 2024. PMID: 38012890 Free article. Clinical Trial.

168

Clinical outcomes and surgical strategy for spine tuberculosis: a systematic review and meta-analysis.

Arifin J, Biakto KT, Johan MP, Anwar SFZ. Arifin J, et al. Spine Deform. 2024 Mar;12(2):271-291. doi: 10.1007/s43390-023-00785-9. Epub 2023 Nov 17. Spine Deform. 2024. PMID: 37975989 Free PMC article. Review.

169

Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB.

Oehadian A, Bastos ML, Centis R, D'Ambrosio L, Migliori GB, Santoso P, Ruslami R, Menzies D. Oehadian A, et al. Pulmonology. 2024 Mar-Apr;30(2):184-187. doi: 10.1016/j.pulmoe.2023.09.003. Epub 2023 Oct 1. Pulmonology. 2024. PMID: 37783640 Free article. No abstract available.

170

Host cell environments and antibiotic efficacy in tuberculosis.

Day NJ, Santucci P, Gutierrez MG. Day NJ, et al. Trends Microbiol. 2024 Mar;32(3):270-279. doi: 10.1016/j.tim.2023.08.009. Epub 2023 Sep 12. Trends Microbiol. 2024. PMID: 37709598 Free article. Review.

171

Impact on tuberculosis diagnostic during COVID-19 pandemic in a tertiary care hospital.

Ruiz-Bastián M, Díaz-Pollán B, Falces-Romero I, Toro-Rueda C, García-Rodríguez J; SARS-CoV-2 Working Group. Ruiz-Bastián M, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Mar;42(3):135-139. doi: 10.1016/j.eimce.2022.11.020. Epub 2023 Feb 1. Enferm Infecc Microbiol Clin (Engl Ed). 2024. PMID: 36737366 Free PMC article.

172

Difference in differences analysis evaluates the effects of the badger control policy on bovine tuberculosis in England.

Birch CPD, Bakrania M, Prosser A, Brown D, Withenshaw SM, Downs SH. Birch CPD, et al. Sci Rep. 2024 Feb 28;14(1):4849. doi: 10.1038/s41598-024-54062-4. Sci Rep. 2024. PMID: 38418486 Free PMC article.

173

Improving TB Case Detection Through Active Case-Finding: Results of Multiple Intervention Strategies in Hard-to-Reach Riverine Areas of Southern Nigeria.

Chukwu JN, Onah CK, Ossai EN, Nwafor CC, Alphonsus C, Ezeakile OE, Murphy-Okpala N, Eze CC, Chijioke-Akaniro O, Meka A, Njoku MI, Iyama FS, Ekeke N. Chukwu JN, et al. Glob Health Sci Pract. 2024 Feb 28;12(1):e2300164. doi: 10.9745/GHSP-D-23-00164. Print 2024 Feb 28. Glob Health Sci Pract. 2024. PMID: 38290754 Free PMC article.

174

Toward tuberculosis elimination by understanding epidemiologic characteristics and risk factors in Hainan Province, China.

Zhou C, Li T, Du J, Yin D, Li X, Li S. Zhou C, et al. Infect Dis Poverty. 2024 Feb 27;13(1):20. doi: 10.1186/s40249-024-01188-2. Infect Dis Poverty. 2024. PMID: 38414000 Free PMC article.

175

Modelling the health and economic impacts ofM72/AS01_E vaccination and BCG-revaccination: Estimates for South Africa.

Sumner T, Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Bakker R, Scarponi D, Hatherill M, Menzies NA, White RG. Sumner T, et al. Vaccine. 2024 Feb 27;42(6):1311-1318. doi: 10.1016/j.vaccine.2024.01.072. Epub 2024 Feb 2. Vaccine. 2024. PMID: 38307747 Free article.

176

Risk factors for tuberculosis-related death among adults with drug-sensitive pulmonary tuberculosis in Selangor, Malaysia from 2013 to 2019: a retrospective cohort study using surveillance data.

Suhairi MH, Mohamad M, Isa MR, Mohd Yusoff MAS, Ismail N. Suhairi MH, et al. BMJ Open. 2024 Feb 26;14(2):e080144. doi: 10.1136/bmjopen-2023-080144. BMJ Open. 2024. PMID: 38413152 Free PMC article.

177

Why do patients with DR-TB do not complete their treatment? Findings of a qualitative study from Pakistan.

Abubakar M, Ullah M, Shaheen MA, Abdullah O. Abubakar M, et al. BMJ Open Respir Res. 2024 Feb 26;11(1):e002186. doi: 10.1136/bmjresp-2023-002186. BMJ Open Respir Res. 2024. PMID: 38413123 Free PMC article.

178

Short Combination Treatment for Latent Tuberculosis in Children.

Cho HK. Cho HK. J Korean Med Sci. 2024 Feb 26;39(7):e97. doi: 10.3346/jkms.2024.39.e97. J Korean Med Sci. 2024. PMID: 38412616 Free PMC article. No abstract available.

179

Current Status of Latent Tuberculosis Infection Treatment Among Pediatric Patients in Korea: Prescription and Treatment Completion.

Kim Y, Bae KS, Choi UY, Han SB, Kim JH. Kim Y, et al. J Korean Med Sci. 2024 Feb 26;39(7):e64. doi: 10.3346/jkms.2024.39.e64. J Korean Med Sci. 2024. PMID: 38412611 Free PMC article.

180

Urokinase in the treatment of tuberculous pleurisy: a systematic review and meta-analysis.

Jing W, Weng R, Lin P, Luo M. Jing W, et al. BMC Infect Dis. 2024 Feb 24;24(1):258. doi: 10.1186/s12879-024-08975-0. BMC Infect Dis. 2024. PMID: 38402168 Free PMC article.

181

Implementing active surveillance for TB: A descriptive survey of healthcare workers in the Eastern Cape, South Africa.

Ajudua FI, Mash RJ. Ajudua FI, et al. Afr J Prim Health Care Fam Med. 2024 Feb 23;16(1):e1-e12. doi: 10.4102/phcfm.v16i1.4217. Afr J Prim Health Care Fam Med. 2024. PMID: 38426777 Free PMC article.

182

Diagnosis and management of tuberculosis infection in inclusion health populations in London.

Gray A, Surey J, Veitch M, Menezes D, Gibbons J, Leonard M, Sultan B, Esmail H, Story A. Gray A, et al. BMC Infect Dis. 2024 Feb 23;24(1):252. doi: 10.1186/s12879-024-09132-3. BMC Infect Dis. 2024. PMID: 38395793 Free PMC article.

183

Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa.

McNabb KC, Bergman AJ, Patil A, Lowensen K, Mthimkhulu N, Budhathoki C, Perrin N, Farley JE. McNabb KC, et al. BMC Public Health. 2024 Feb 23;24(1):578. doi: 10.1186/s12889-024-17924-0. BMC Public Health. 2024. PMID: 38389038 Free PMC article.

184

Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.

Biset S, Teferi M, Alamirew H, Birhanu B, Dessie A, Aschale A, Haymanot A, Dejenie S, Gebremedhin T, Abebe W, Adane G. Biset S, et al. BMC Infect Dis. 2024 Feb 22;24(1):238. doi: 10.1186/s12879-024-09135-0. BMC Infect Dis. 2024. PMID: 38389060 Free PMC article.

185

Association between statin use and tuberculosis risk in patients with bronchiectasis: a retrospective population-based cohort study in Taiwan.

Liao KM, Lee CS, Wu YC, Shu CC, Ho CH. Liao KM, et al. BMJ Open Respir Res. 2024 Feb 22;11(1):e002077. doi: 10.1136/bmjresp-2023-002077. BMJ Open Respir Res. 2024. PMID: 38387995 Free PMC article.

186

Azetidines Kill Multidrug-Resistant Mycobacterium tuberculosis without Detectable Resistance by Blocking Mycolate Assembly.

Cui Y, Lanne A, Peng X, Browne E, Bhatt A, Coltman NJ, Craven P, Cox LR, Cundy NJ, Dale K, Feula A, Frampton J, Fung M, Morton M, Goff A, Salih M, Lang X, Li X, Moon C, Pascoe J, Portman V, Press C, Schulz-Utermoehl T, Lee S, Tortorella MD, Tu Z, Underwood ZE, Wang C, Yoshizawa A, Zhang T, Waddell SJ, Bacon J, Alderwick L, Fossey JS, Neagoie C. Cui Y, et al. J Med Chem. 2024 Feb 22;67(4):2529-2548. doi: 10.1021/acs.jmedchem.3c01643. Epub 2024 Feb 8. J Med Chem. 2024. PMID: 38331432 Free PMC article.

187

HIV-TB Coinfection: Current Therapeutic Approaches and Drug Interactions.

Navasardyan I, Miwalian R, Petrosyan A, Yeganyan S, Venketaraman V. Navasardyan I, et al. Viruses. 2024 Feb 21;16(3):321. doi: 10.3390/v16030321. Viruses. 2024. PMID: 38543687 Free PMC article. Review.

188

Delays in health seeking, diagnosis and treatment for tuberculosis patients in Mongolia: an analysis of surveillance data, 2018-2021.

Otero L, Boldoo T, Purevdagva A, Borgil U, Enebish T, Erdenee O, Islam T, Morishita F. Otero L, et al. Western Pac Surveill Response J. 2024 Feb 21;15(1):1-9. doi: 10.5365/wpsar.2024.15.1.1074. eCollection 2024 Jan-Mar. Western Pac Surveill Response J. 2024. PMID: 38500777 Free PMC article.

189

Inferring Mycobacterium Tuberculosis Drug Resistance and Transmission using Whole-genome Sequencing in a High TB-burden Setting in China.

Fan YF, Liu DX, Chen YW, Ou XC, Mao QZ, Yang TT, Wang XJ, He WC, Zhao B, Liu ZJ, Abulimiti M, Aihemuti M, Gao Q, Zhao YL. Fan YF, et al. Biomed Environ Sci. 2024 Feb 20;37(2):157-169. doi: 10.3967/bes2023.116. Biomed Environ Sci. 2024. PMID: 38582978 Free article.

190

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.

Semitala FC, Kadota JL, Musinguzi A, Welishe F, Nakitende A, Akello L, Kunihira Tinka L, Nakimuli J, Ritar Kasidi J, Bishop O, Nakasendwa S, Baik Y, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Katahoire A, Berger CA, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A. Semitala FC, et al. PLoS Med. 2024 Feb 20;21(2):e1004356. doi: 10.1371/journal.pmed.1004356. eCollection 2024 Feb. PLoS Med. 2024. PMID: 38377166 Free PMC article. Clinical Trial.

191

Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.

Nimmo C, Ortiz AT, Tan CCS, Pang J, Acman M, Millard J, Padayatchi N, Grant AD, O'Donnell M, Pym A, Brynildsrud OB, Eldholm V, Grandjean L, Didelot X, Balloux F, van Dorp L. Nimmo C, et al. Genome Med. 2024 Feb 19;16(1):34. doi: 10.1186/s13073-024-01289-5. Genome Med. 2024. PMID: 38374151 Free PMC article.

192

Unsuccessful tuberculosis treatment outcomes across Brazil's geographical landscape before and during the COVID-19 pandemic: are we truly advancing toward the sustainable development/end TB goal?

Tavares RBV, Berra TZ, Alves YM, Popolin MAP, Ramos ACV, Tártaro AF, de Souza CF, Arcêncio RA. Tavares RBV, et al. Infect Dis Poverty. 2024 Feb 18;13(1):17. doi: 10.1186/s40249-024-01184-6. Infect Dis Poverty. 2024. PMID: 38369536 Free PMC article.

193

Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy.

Alonso-Rodríguez N, Vianello E, van Veen S, Jenum S, Tonby K, van Riessen R, Lai X, Mortensen R, Ottenhoff THM, Dyrhol-Riise AM. Alonso-Rodríguez N, et al. Front Immunol. 2024 Feb 16;15:1350593. doi: 10.3389/fimmu.2024.1350593. eCollection 2024. Front Immunol. 2024. PMID: 38433842 Free PMC article.

194

A systematic review and meta-analysis of intraarterial chemotherapy for non muscle invasive bladder cancer: Promising alternative therapy in high tuberculosis burden countries.

Rahman ZA, Hidayatullah F, Lim J, Hakim L. Rahman ZA, et al. Arch Ital Urol Androl. 2024 Feb 16;96(1):12154. doi: 10.4081/aiua.2024.12154. Arch Ital Urol Androl. 2024. PMID: 38363237 Free article.

195

Ubuntu Is a Critical Component in the Fight against Human Immunodeficiency Virus and Tuberculosis Stigma: Nursing Students' Perceptions.

Rasweswe MM, Kgatla NM, Ramavhoya IT, Mulaudzi FM. Rasweswe MM, et al. Int J Environ Res Public Health. 2024 Feb 15;21(2):229. doi: 10.3390/ijerph21020229. Int J Environ Res Public Health. 2024. PMID: 38397718 Free PMC article.

196

Prevalence of Rifampicin resistance tuberculosis among presumptive tuberculosis patients in Egypt-2021: a national health facility-based survey.

Amin W, Gadallah M, Salah A, Rady M. Amin W, et al. BMC Infect Dis. 2024 Feb 15;24(1):210. doi: 10.1186/s12879-023-08807-7. BMC Infect Dis. 2024. PMID: 38360617 Free PMC article.

197

Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset.

Njiro BJ, Kisonga R, Joachim C, Sililo GA, Nkiligi E, Ibisomi L, Chirwa T, Francis JM. Njiro BJ, et al. PLoS Negl Trop Dis. 2024 Feb 15;18(2):e0011968. doi: 10.1371/journal.pntd.0011968. eCollection 2024 Feb. PLoS Negl Trop Dis. 2024. PMID: 38359088 Free PMC article.

198

Nutritional status and treatment outcomes of tuberculosis in Mizan Tepi University Teaching Hospital, a five -year retrospective study.

Simieneh A, Gashaneh S, Dereje R. Simieneh A, et al. PLoS One. 2024 Feb 15;19(2):e0298244. doi: 10.1371/journal.pone.0298244. eCollection 2024. PLoS One. 2024. PMID: 38359007 Free PMC article.

199

Efficacy of Intrathecal Isoniazid and Steroid Therapy in Refractory Tuberculous Meningitis.

Ashizawa N, Kubo R, Tagawa R, Ito Y, Takeda K, Ide S, Iwanaga N, Fujita A, Tashiro M, Takazono T, Tanaka T, Nagaoka A, Yoshimura S, Ujifuku K, Koga T, Ishii K, Yamamoto K, Furumoto A, Izumikawa K, Yanagihara K, Mukae H. Ashizawa N, et al. Intern Med. 2024 Feb 15;63(4):583-586. doi: 10.2169/internalmedicine.1917-23. Epub 2023 Jun 21. Intern Med. 2024. PMID: 37344431 Free PMC article.

200

On the onset and dispersal of a major MDR TB clone among HIV-negative patients, Tunisia.

Dekhil N, Mardassi H. Dekhil N, et al. Antimicrob Resist Infect Control. 2024 Feb 14;13(1):18. doi: 10.1186/s13756-023-01360-7. Antimicrob Resist Infect Control. 2024. PMID: 38355557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18,939 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18,939 results

Results by year